Prof.Ding Group Showcases Innovative Healthcare Products At 90th PHARMCHINA

May 30, 2025

Leave a message

GUANGZHOU, China – May 21, 2025​​ – The 90th National Pharmaceutical Fair (PHARMCHINA), a cornerstone event for China's pharmaceutical and healthcare industry, concluded successfully on May 23rd in Guangzhou. The prestigious fair attracted nearly 4,000 leading enterprises from across the nation's vast healthcare sector.

Prof.Ding Group, a prominent player in the industry, was a significant participant at this landmark event. The group seized the platform to unveil and highlight its latest portfolio of healthcare solutions, generating considerable interest among attendees.

​Key products showcased included:​

​New Eye Drops:​​ Featuring an innovative formula designed for enhanced comfort and efficacy.

​Advanced Pain Relief Patches:​​ Offering targeted relief and improved transdermal delivery.

​Pharyngitis Relief Pills:​​ A specialized herbal formulation for soothing throat discomfort.

The group's exhibition proved highly effective, resulting in the ​​successful securing of over a dozen on-site orders​​ from distributors and partners nationwide. This robust response underscores the market demand for Ding Professor Group's new offerings and its strong industry reputation.

"The 90th National Pharmaceutical Fair provided an exceptional platform for us to connect with the industry and present our latest innovations," said a spokesperson for Prof.Ding Group. "The enthusiastic reception and immediate commercial success of our new eye drops, patches, and pharyngitis pills validate our commitment to developing high-quality, effective healthcare products that meet evolving market needs. We are energized by the positive feedback and new partnerships forged here in Guangzhou."

​About Ding Prof.Ding Group:​
Prof.Ding Group is one of the best enterprise in China's healthcare sector, dedicated to the research, development, production, and distribution of high-quality pharmaceuticals and health products. The group is committed to innovation, stringent quality control, and improving public health outcomes.

news-4160-3120

news-4160-3120

Send Inquiry